A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis

被引:8
作者
Perumpail, Ryan B. [1 ]
Wong, Robert J. [2 ]
Pham, Edward A. [1 ]
Higgins, John P. [3 ]
Daugherty, Tami J. [1 ]
Ahmed, Aijaz [1 ]
机构
[1] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94304 USA
[2] Alameda Hlth Syst, Div Gastroenterol & Hepatol, Oakland, CA USA
[3] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
关键词
Sustained Virological Response; Sofosbuvir; Standard Recommended Dose; Combination Antiviral Treatment;
D O I
10.1007/s10620-015-3756-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:39 / 41
页数:3
相关论文
共 5 条
[1]  
[Anonymous], 2014, REC TEST MAN TREAT H
[2]  
Cornpropst M, 2012, INT LIV C 2012 47 AN
[3]   Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study [J].
Lawitz, Eric ;
Sulkowski, Mark S. ;
Ghalib, Reem ;
Rodriguez-Torres, Maribel ;
Younossi, Zobair M. ;
Corregidor, Ana ;
DeJesus, Edwin ;
Pearlman, Brian ;
Rabinovitz, Mordechai ;
Gitlin, Norman ;
Lim, Joseph K. ;
Pockros, Paul J. ;
Scott, John D. ;
Fevery, Bart ;
Lambrecht, Tom ;
Ouwerkerk-Mahadevan, Sivi ;
Callewaert, Katleen ;
Symonds, William T. ;
Picchio, Gaston ;
Lindsay, Karen L. ;
Beumont, Maria ;
Jacobson, Ira M. .
LANCET, 2014, 384 (9956) :1756-1765
[4]  
Lawitz E, 2013, NEW ENGL J MED, V369, P678, DOI [10.1056/NEJMoa1214853, 10.1056/NEJMc1307641]
[5]   Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis [J].
Perumpail, R. B. ;
Wong, R. J. ;
Ha, L. D. ;
Pham, E. A. ;
Wang, U. ;
Luong, H. ;
Kumari, R. ;
Daugherty, T. J. ;
Higgins, J. P. ;
Younossi, Z. M. ;
Kim, W. R. ;
Glenn, J. S. ;
Ahmed, A. .
TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) :275-278